279227-02-0 Usage
Description
1-(2-Hydroxy-ethyl)-2-methyl-1H-benzoimidazole-5-carboxylic acid is a chemical compound belonging to the benzimidazole family, known for its diverse biological activities such as antifungal, antiparasitic, and antiviral properties. 1-(2-HYDROXY-ETHYL)-2-METHYL-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID features a hydroxyethyl group and a carboxylic acid group, which may contribute to its solubility and potential binding capabilities with target receptors or enzymes. Further research is necessary to fully comprehend its therapeutic potential and explore its applications in drug development.
Uses
Used in Pharmaceutical Industry:
1-(2-Hydroxy-ethyl)-2-methyl-1H-benzoimidazole-5-carboxylic acid is used as a potential therapeutic agent for its demonstrated antifungal, antiparasitic, and antiviral properties. Its unique structure with a hydroxyethyl group and a carboxylic acid group allows for possible interactions with target receptors or enzymes, making it a candidate for drug development.
Used in Drug Development:
In the field of drug development, 1-(2-Hydroxy-ethyl)-2-methyl-1H-benzoimidazole-5-carboxylic acid is utilized as a compound with potential applications in creating new medications. Its solubility and binding capabilities may be harnessed to improve the efficacy and specificity of drugs targeting various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 279227-02-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,9,2,2 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 279227-02:
(8*2)+(7*7)+(6*9)+(5*2)+(4*2)+(3*7)+(2*0)+(1*2)=160
160 % 10 = 0
So 279227-02-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H12N2O3/c1-7-12-9-6-8(11(15)16)2-3-10(9)13(7)4-5-14/h2-3,6,14H,4-5H2,1H3,(H,15,16)/p-1
279227-02-0Relevant articles and documents
Synthesis and biological activity of new functionalized epothilones for prodrug design and tumor targeting
Dietrich, Silvia Anthoine,Riediker, Linda,Gertsch, Juerg,Altmann, Karl-Heinz
, p. 136 - 139 (2011/07/31)
Epothilones are potent antiproliferative agents, which have served as successful lead structures for anticancer drug discovery. However, their therapeutic efficacy would benefit greatly from an increase in their selectivity for tumor cells, which may be a
INHIBITORS OF HISTONE DEACETYLASE
-
Page/Page column 252-253, (2010/02/11)
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.